Ostrum Asset Management’s Pfizer PFE Stock Holding History

Ostrum Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.89M	Sell	119,911 -4,347	-3%	-$114K	0.14%	107
2026 Q1	$3.49M	Sell	124,258 -10,249	-8%	-$273K	0.2%	73
2025 Q4	$3.35M	Sell	134,507 -30,678	-19%	-$774K	0.16%	94
2025 Q3	$4.21M	Buy	165,185 +8,076	+5%	+$199K	0.19%	87
2025 Q2	$3.81M	Buy	157,109 +25,373	+19%	+$592K	0.18%	100
2025 Q1	$3.34M	Sell	131,736 -69,652	-35%	-$1.82M	0.18%	105
2024 Q4	$5.34M	Buy	201,388 +34,354	+21%	+$932K	0.46%	37
2024 Q3	$4.83M	Sell	167,034 -1,230	-0.7%	-$35.9K	0.4%	50
2024 Q2	$4.71M	Sell	168,264 -66,513	-28%	-$1.83M	0.41%	48
2024 Q1	$6.52M	Sell	234,777 -22,478	-9%	-$624K	0.51%	26
2023 Q4	$7.41M	Buy	257,255 +85,681	+50%	+$2.59M	0.64%	17
2023 Q3	$5.69M	Sell	171,574 -40,693	-19%	-$1.44M	0.53%	27
2023 Q2	$7.79M	Sell	212,267 -2,685	-1%	-$105K	0.65%	14
2023 Q1	$8.77M	Buy	+214,952	New	+$9.28M	0.76%	9

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ostrum Asset Management's PFE Position: Q2 2026 in Review

Ostrum Asset Management reduced its Pfizer (PFE) stake by 3.5% in Q2 2026, selling an estimated $114K and leaving 119,911 shares worth $2.89M. The position accounts for 0.14% of the portfolio, ranked #107.

Ostrum Asset Management first reported a position in PFE in Q1 2023 and has held it in 14 quarters since. The position peaked at $8.77M in Q1 2023. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Ostrum Asset Management held 119,911 shares of Pfizer worth $2.89M as of Q2 2026.
Ostrum Asset Management sold 4,347 Pfizer shares in Q2 2026, an estimated $114K.
Pfizer made up 0.14% of Ostrum Asset Management's portfolio in Q2 2026, its #107 holding.
Ostrum Asset Management first reported a position in Pfizer in Q1 2023 and has held it in 14 quarters since.
Ostrum Asset Management's Pfizer position peaked at $8.77M in Q1 2023.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ostrum Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.